Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer - Concepedia

Concepedia

Publication | Open Access

Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer

DOI Full Paper Access

22

Citations

63

References

2021

Year

Ratika Kunder, Michelle Velyunskiy, Sara F. Dunne, Byoung-Kyu Cho, Deepak Kanojia, Lauren R. Begg, Adrienne Orriols, Erica Fleming-Trujillo, Pranathi Vadlamani, A. Vialichka,

Cell chemical biology

Proteasome InhibitionBreast OncologyMedicineTherapeutic StrategySynergistic Pim KinaseBreast CancerCancer BiologyTumor SuppressorCancer TreatmentRadiation OncologyOncologyCell BiologyTumor MicroenvironmentTumor BiologyCancer Growth

References

	Year	Citations

Page 1

Page 1